mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.005 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.005 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.005 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.005 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.005 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.006 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
0.006 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.006 |